Overview
Hereditary poikiloderma (Orphanet code 222628) is a group of rare inherited skin disorders characterized by poikiloderma, a distinctive combination of skin changes that includes reticulated (net-like) hypo- and hyperpigmentation, skin atrophy, and telangiectasia (small dilated blood vessels). These changes typically develop in early life and primarily affect the skin, though associated features may vary depending on the specific subtype. The term 'hereditary poikiloderma' serves as a broad grouping category that encompasses several distinct genetic conditions sharing the hallmark poikilodermatous skin findings. The skin manifestations usually begin in infancy or childhood and may be photosensitive, worsening with sun exposure. Depending on the specific underlying condition, patients may also experience skeletal abnormalities, short stature, sparse hair, nail dystrophy, cataracts, or an increased susceptibility to certain cancers. The most well-known conditions within this spectrum include Rothmund-Thomson syndrome, Kindler syndrome, and other hereditary poikiloderma subtypes, each with distinct genetic causes and associated systemic features. There is currently no cure for hereditary poikiloderma. Management is primarily supportive and symptomatic, focusing on strict sun protection, dermatologic surveillance, and monitoring for associated complications such as malignancies or skeletal problems. Genetic counseling is recommended for affected families. Regular follow-up with a multidisciplinary team including dermatologists, ophthalmologists, and oncologists may be warranted depending on the specific diagnosis within this disease group.
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hereditary poikiloderma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary poikiloderma at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary poikiloderma.
Community
No community posts yet. Be the first to share your experience with Hereditary poikiloderma.
Start the conversation →Latest news about Hereditary poikiloderma
No recent news articles for Hereditary poikiloderma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary poikiloderma
What is Hereditary poikiloderma?
Hereditary poikiloderma (Orphanet code 222628) is a group of rare inherited skin disorders characterized by poikiloderma, a distinctive combination of skin changes that includes reticulated (net-like) hypo- and hyperpigmentation, skin atrophy, and telangiectasia (small dilated blood vessels). These changes typically develop in early life and primarily affect the skin, though associated features may vary depending on the specific subtype. The term 'hereditary poikiloderma' serves as a broad grouping category that encompasses several distinct genetic conditions sharing the hallmark poikilodermat
At what age does Hereditary poikiloderma typically begin?
Typical onset of Hereditary poikiloderma is childhood. Age of onset can vary across affected individuals.
Which specialists treat Hereditary poikiloderma?
1 specialists and care centers treating Hereditary poikiloderma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.